Auro Laboratories Limited has scheduled a meeting of the Board of Directors for Friday, May 29, 2026. The primary agenda items for the meeting include:
- Consideration and approval of the Audited Financial Results of the Company along with the Report of the Auditors for the Quarter and Year Ended March 31, 2026
- Consideration of any other matter with the permission of the Chair
The company has confirmed that in accordance with its Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations 2015, the trading window for dealing in the securities of the Company has been closed since April 01, 2026. The trading window will re-open 48 hours after the announcement of the Financial Results to the Stock Exchange.
This intimation is being made pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure has also been uploaded on the Company's website at www.aurolabs.com.